JEANNINE SHEPPARD: Open Payments
NPI 1720105109 · DAYTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,165 in 60 payments from 11 companies in 2025. Trend: 2023 $1,490 · 2024 $1,822 · 2025 $1,165
Food & beverage: $1,153Education: $11
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $208 |
| Axsome Therapeutics, Inc. | 11 | $204 |
| Teva Pharmaceuticals USA, Inc. | 9 | $196 |
| Alkermes, Inc. | 13 | $164 |
| Otsuka America Pharmaceutical, Inc. | 4 | $98 |
| Lundbeck LLC | 4 | $77 |
| ABBVIE INC. | 4 | $65 |
| Vanda Pharmaceuticals Inc. | 3 | $50 |
| Neurocrine BioSciences, Inc. | 2 | $42 |
| Janssen Pharmaceuticals, Inc | 2 | $36 |
Products named: CAPLYTA, Auvelity, ARISTADA, AUSTEDO XR, UZEDY, ABILIFY ASIMTUFII, VRAYLAR, REXULTI.
Industry payments across OH — which companies pay providers there.
